GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications

YONGIN, South Korea, April 11, 2023 /PRNewswire/ — GC Genome Corporation, a leading genomic diagnostics company, today announced the publication of a new study in Nature Communications, showcasing the company’s novel AI-based liquid biopsy technology. The study highlights the…